Diamonrecta 20 mg 4 tablets

Diamonrecta 20 mg 4 tablets

Composition:
Each tablet contains:
Tadalafil 20 mg.
Inactive ingredients:
Lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose, microcrystalline cellulose, magnesium stearate.
Properties:
Tadalafil is a reversible selective inhibitor of specific phosphodiesterase type 5 (PDE5) cyclic guanosine monophosphate (cGMP).
When sexual arousal causes local release of nitric oxide, inhibition of PDE5 by tadalafil leads to an increase in the concentration of cGMP in the cavernous body of the penis.
The consequence of this is the relaxation of the smooth muscles of the arteries and the flow of blood to the tissues of the penis, which causes an erection.
Tadalafil has no effect in the absence of sexual arousal.
Indications:
- Erectile dysfunction;
- Symptoms of the lower urinary tract in patients with benign prostatic hyperplasia (for a dosage of 5 mg);
- Erectile dysfunction in patients with symptoms of the lower urinary tract against the background of benign prostatic hyperplasia (for a dosage of 5 mg).
Dosage and administration:
The drug is taken orally.
Erectile dysfunction:
For patients with frequent sexual activity (more than 2 times a week): the recommended frequency of administration is daily, 1 time / day, 5 mg, at the same time, regardless of food intake. 
The daily dose may be reduced to 2.5 mg (1/2 tab. 5 mg) depending on individual sensitivity.
For patients with infrequent sexual activity (less than 2 times a week), it is recommended to prescribe the drug at a dose of 20 mg, immediately before sexual activity, according to the instructions for the medical use of the drug.
The maximum daily dose of the drug is 20 mg.
BPH or erectile dysfunction/BPH:
The recommended dose of the drug tadalafil when used 1 time / day is 5 mg;
The drug should be taken at approximately the same time of day, regardless of the time of sexual activity.
The duration of treatment is determined by the doctor individually.
Contraindications:
- The use of drugs containing any organic nitrates;
- The presence of contraindications to sexual activity in patients with diseases of the cardiovascular system.
- Loss of vision due to non-arterial anterior ischemic optic neuropathy (regardless of the connection with the intake of PDE5 inhibitors);
- Simultaneous use with doxazosin, other PDE5 inhibitors, other treatment options for erectile dysfunction, with guanylate cyclase stimulants such as riociguat;
- Chronic renal failure (CC less than 30 ml / min);
- Age up to 18 years;
- Lactase deficiency, lactose intolerance, glucose-galactose malabsorption;
- Hypersensitivity to tadalafil or to any substance that is part of the drug.
Warnings and precautions:
- Diagnosis of erectile dysfunction should include identification of a potential underlying cause, appropriate medical evaluation, and determination of treatment tactics.
- Sexual activity has a potential risk for patients with cardiovascular disease. 
Therefore, the treatment of erectile dysfunction, incl. tadalafil should not be used in men with heart conditions for which sexual activity is not recommended.
Side effects:
Nervous system: often - headache; infrequently - dizziness.
Vessels: often - “tides” of blood to the face; infrequently - a decrease in blood pressure, an increase in blood pressure.
Respiratory system: often - nasal congestion.
Digestive system: often - dyspepsia.
Musculoskeletal system: often - back pain, myalgia, pain in the extremities.
Storage:
Store at a temperature not exceeding 30°C.
Package:
The carton box contains 4 tablets, paper leaflet.